Paliperidon Ratiopharm (Paliperidone)

Paliperidone, the active ingredient in Paliperidon Ratiopharm, is an atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and schizoaffective disorder in adults. GNH USA supplies Paliperidon Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Paliperidon Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paliperidone is an atypical antipsychotic that modulates dopamine and serotonin pathways in psychotic disorders.

- Schizophrenia: helps reduce hallucinations, delusions and thought disorder. - Schizoaffective disorder: improves mood symptoms and psychotic features. - Maintenance therapy: helps prevent relapse of psychotic symptoms after stabilization.

Paliperidone may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Akathisia: feeling ​​ ​ ​ ​ ​ ​ ​ restlessness ​ ​​ ​ ​ ​ ​ ​ ​ - Weight gain: increase ​ ​in ​ ​body ​ ​mass ​ ​index. - Somnolence: drowsiness or fatigue ​​ - Dry mouth: reduced salivation. - Constipation: slowed gastrointestinal motility. - Increased prolactin: menstrual irregularities or galactorrhea.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Tardive dyskinesia: involuntary, repetitive movements. - Seizures: risk of new‑onset seizures. - Orthostatic      ​     ​  ​  ​  ​  ​             ​                           ​     </...>

Paliperidone  ​​   …  …  ...  …  ...  ...  ...  ... … … … …  … … 

...